Senior Oncology Category Lead - SOLA LATAM

Pfizer

Buenos Aires

On-site

ARS 278,173,000 - 401,805,000

Full time

2 days ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Pfizer seeks an Oncology Category Lead for SOLA, overseeing P&L across Argentina, Bolivia, Chile, Peru, Paraguay and Uruguay. You will shape strategy, align cross-functional teams, and engage external stakeholders to drive patient access, revenue growth, and portfolio sustainability.

This is a high-visibility, senior leadership role in a matrix environment. The role requires 8+ years in pharma, strong strategic and leadership capabilities, and the ability to operate across multi-market dynamics.

Qualifications

  • BA/BS with at least 8 years of experience.
  • Proven track record of delivering exceptional results as a leader of teams and organizations.
  • Demonstrated ability to think and act strategically, with relevant experience in Pharmaceutical Marketing, Commercial Development, Strategy, or Analytics.
  • Proficient in providing proactive and constructive feedback to individuals to enhance performance.
  • Strong project and change leadership skills.

Responsibilities

  • Own end-to-end P&L accountability for the Oncology portfolio across SOLA markets.
  • Define and pursue a winning aspiration for the Oncology Category and opportunities to grow.
  • Lead cross-functional teams and align Medical Affairs, Access, Commercial, Finance, and regional/global counterparts.
  • Embed compliance and integrity into all commercial programs and field interactions.
  • Champion omnichannel engagement and patient access across diverse market environments.

Skills

Leadership
Strategic thinking
Cross-functional collaboration
Analytics
Change management

Education

BA/BS

Job description

Pfizer seeks an Oncology Category Lead for SOLA, overseeing P&L across Argentina, Bolivia, Chile, Peru, Paraguay and Uruguay. You will shape strategy, align cross-functional teams, and engage external stakeholders to drive patient access, revenue growth, and portfolio sustainability.

This is a high-visibility, senior leadership role in a matrix environment. The role requires 8+ years in pharma, strong strategic and leadership capabilities, and the ability to operate across multi-market dynamics.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Oncology Category Lead, SOLA - LatAm Growth & Access
Oncology Category Lead, SOLA - LatAm Growth & Access

Pfizer Inc • Buenos Aires

Hybrid
ARS 278,173,000 - 432,713,000
Frequent business travel
On-site 2-3x/week
Senior Oncology Category Lead, LATAM Growth & Access
Senior Oncology Category Lead, LATAM Growth & Access

Pfizer Inc • San Isidro

On-site
ARS 340,668,000 - 495,517,000
Senior Oncology Category Lead – SOLA P&L & Strategy
Senior Oncology Category Lead – SOLA P&L & Strategy

Biopharma Asia • Buenos Aires

Hybrid
ARS 278,173,000 - 370,897,000
SOLA Regional Oncology Lead: Growth & Access
SOLA Regional Oncology Lead: Growth & Access

Pfizer • Municipio de Rincón de los Sauces

On-site
ARS 387,123,000 - 541,972,000
Oncology Category Lead South Latam
Oncology Category Lead South Latam

Pfizer • Municipio de Rincón de los Sauces

On-site
ARS 387,123,000 - 541,972,000
Oncology Category Lead South Latam
Oncology Category Lead South Latam

Biopharma Asia • Buenos Aires

Hybrid
ARS 278,173,000 - 370,897,000
Oncology Category Lead South Latam
Oncology Category Lead South Latam

Pfizer • Buenos Aires

On-site
ARS 278,173,000 - 401,805,000
Oncology Category Lead South Latam
Oncology Category Lead South Latam

731 Pfizer S.R.L. • San Isidro

On-site
ARS 340,668,000 - 495,517,000
Oncology Category Lead South Latam
Oncology Category Lead South Latam

Pfizer Pte Ltd. • Buenos Aires

Hybrid
ARS 278,173,000 - 432,713,000
Frequent business travel
On-site 2-3x/week
LATAM Insights & Analytics Manager - Oncology Strategy
LATAM Insights & Analytics Manager - Oncology Strategy

Johnson and Johnson • Buenos Aires

Hybrid
ARS 181,906,000 - 242,542,000